Acadia Pharma's psychosis drug proven better than placebo in dementia patients

Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo.

from Reuters: Health News https://ift.tt/33QyWbB
via IFTTT